Loading provider…
Loading provider…
Ophthalmology Physician in Mountain View, CA
NPI: 1538295720Primary Employer
Northern California Retina Vitreous Associates Medical Group, Inc.
ncrva.com
HQ Phone
Get M.D., PH.D. Louis's Phone Numberphone_androidMobile
Get M.D., PH.D. Louis's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
2013 - 2026
NY State Medical License
2007 - 2014
CA State Medical License

American Board of Ophthalmology
Ophthalmology
University Of Washington School Of Medicine
uwmedicine.washington.edu
Medical School
Until 2003
WashU Medicine
medicine.washu.edu
Medical School
Until 2003
UCLA David Geffen School of Medicine/UCLA Medical Center/UCLA Stein and Doheny Eye Institutes
Residency • Ophthalmology
2004 - 2007
Los Angeles County-Harbor-UCLA Medical Center
Internship • Transitional Year
2003 - 2004
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 92134Diagnostic imaging of retina | 530 | 2,038 |
| 2 | 92012Eye and medical examination for diagnosis and treatment, established patient | 383 | 1,026 |
| 3 | 67028Injection of drug into eye | 230 | 1,293 |
| 4 | 92014Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | 225 | 225 |
| 5 | J0178Injection, aflibercept, 1 mg | 182 | 2,075 |
PREDICTORS OF Anti-VEGF-ASSOCIATED RETINAL PIGMENT EPITHELIAL TEAR USING FA
Authors: Chiang, Allen, Chang, Louis K, Yu, Fei, Sarraf, David
Journal: Retina
Disruption of the photoreceptor inner segment-outer segment junction in eyes
Authors: Chang, Louis K, Koizumi, Hideki, Spaide, Richard F
Journal: Retina
PROSPECTIVE EVALUATION OF A SUSTAINED-RELEASE DEXAMETHASONE INTRAVITREAL IMPLANT
Authors: Khurana, Rahul N, Bansal, Alok S, Chang, Louis K, Palmer, James D, Wu, Chengqing, Wieland, Mark R
Journal: Retina
Lead Sponsor: Southern California Desert Retina Consultants, MC
Intervention / Treatment: DRUG: Ranibizumab 0.5mg